Grown Rogue International (GRUSF) EPS (Diluted) Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) EPS (Diluted) Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.12% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.26% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.43% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.24% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.96% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.19% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.62% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -1,104.96% |
| Jul 31, 2023 | 115.08% |
| Apr 30, 2023 | 128.32% |
| Jan 31, 2023 | 171.84% |
| Jan 31, 2022 | -50.99% |
| Jul 31, 2021 | 73.40% |
| Apr 30, 2021 | 0.54% |
| Jan 31, 2021 | 5.97% |
| Feb 28, 2018 | -2,958.13% |
| Aug 31, 2016 | 36,021.96% |
| Feb 29, 2016 | 97.28% |
| Feb 28, 2015 | 25.99% |
| Aug 31, 2014 | -26.08% |
| May 31, 2014 | 95.47% |
| Aug 31, 2013 | 25.99% |
| Feb 28, 2013 | -57.79% |
| Aug 31, 2012 | 108.59% |
| May 31, 2012 | -427.25% |
| Feb 29, 2012 | -777.11% |